IGHE and asthma: Each variable was given a different scoring point according to its β value (Table 5), and a scoring system (FAIE; Female, Allergic rhinitis, IgE, and Eosinophil) ranging from 0 to 6; with 0 = no risk and 6 = high risk; was established accordingly to screen for comorbid asthma in patients with CRSwNP.